• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

A not-for-profit health and tax policy research organization.

  • Home
  • About Us
    • Mission and History
    • Officers and Trustees
    • Scholars and Staff
    • Who was Galen?
  • Activities
    • Core Activities
    • State Leaders Calls
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Donate
  • Contact Us
  • Major Papers
  • Broadcast Interviews
  • Health Policy Consensus Group

Congress Should Say No to Cutting Drug Subsidies for Low-Income Seniors

POSTED BY Grace-Marie Turner | RealClearHealth on November 20, 2015.

President Barack Obama and congressional appropriators are looking for savings to offset new federal spending programs.  One proposal on the table – drawn from the president’s budget plan – would disproportionately impact low-income seniors who rely on prescription medications for serious medical conditions.

The measure, estimated to save $8.9 billion over ten years, would increase copayments for brand name drugs for Medicare Part D beneficiaries who receive extra financial assistance under the Low Income Subsidy (LIS) program.

Forcing low-income seniors to pay more for brand-name medications could impact the quality of health care for one of the most vulnerable populations in Medicare by limiting their access to needed medicines, and it could result in higher costs for taxpayers.

The policy being contemplated targets individuals with incomes up to 150 percent of the federal poverty level (about $17,700 a year for individuals) who also have limited assets. The LIS program reduces their out-of-pocket spending by paying some or all of their Part D monthly premiums and annual deductibles — and also limiting their co-insurance or copayments.

Continue reading on RealClearHealth…

Filed Under: Prescription Drugs

Primary Sidebar

NEW – OF INTEREST

Health Care Choices 20/20:

A Vision for the Future


See the latest interview of Grace-Marie Turner on C-SPAN

SEARCH

Categories

  • Brian Blase
  • Consumer-Directed Care
  • Doug Badger
  • Grace-Marie Turner
  • Health Insurance
  • Health Policy Consensus Group
  • Health Savings Accounts
  • Innovation
  • Medicaid
  • Medicare
  • Newsletter
  • ObamaCare
  • Prescription Drugs
  • Published
    • Forbes
    • Fox Business
    • Health Affairs
    • LA Times
    • National Review
    • New York Post
    • RealClearHealth
    • Sun Sentinel
    • The Daily Signal
    • The Hill
    • The New York Times
    • The Wall Street Journal
    • The Washington Times
  • Reform Initiatives
  • State Issues
  • Uncategorized

LATEST NEWSLETTER ISSUES

SUBSCRIBE

Social Media

Like Us On Facebook

Twitter: @galeninstitute

 

Copyright Galen Institute, Inc © 2021; · Log in